Vaccines Shield Immune System from Persistent Damage Following Viral Infection, Study Finds

Vaccines may provide more than immediate protection against viral illness. New research indicates they could also prevent enduring harm to the immune system that persists after the pathogen is cleared from the body.

Scientists at Pompeu Fabra University have shown that mice recovering from an acute viral infection experience prolonged impairment of their immune defenses. Even though the animals successfully eliminated the virus, their immune systems remained compromised, making it harder to respond to new pathogens. Importantly, mice that were vaccinated prior to infection did not develop these long‑term deficits, suggesting that immunization offers an additional layer of protection beyond preventing overt disease.

Common viral infections such as colds or gastrointestinal viruses are typically viewed as transient illnesses. The conventional model assumes that once symptoms subside and the virus is controlled, the body has fully recovered and is back to normal. The immune response also generates memory that protects against subsequent encounters with the same virus.

However, what if the immune system continues to suffer harmful effects long after the infection appears resolved?

Viral Infections Can Leave Lasting Immune Damage

Researchers from Pompeu Fabra University’s Infection Biology Laboratory explored this possibility in a study published in Cell Death & Disease. Using a mouse model of acute viral infection, the team examined immune function after viral clearance.

They discovered that eliminating the virus did not fully restore normal immune activity. Instead, the infection left behind persistent changes that endured well beyond the acute phase. According to Andreas Meyerhans, an ICREA research professor at UPF who led the work, “there is a general perception that an acute viral infection is a relatively minor and transient event: once the virus is controlled and the symptoms have resolved, the body has fully recovered and is back to normal. But this view may underestimate consequences that are not immediately visible and can persist long after the infection itself has resolved.”

The investigation pinpointed these lingering effects to significant alterations in the spleen, a key organ for coordinating immune responses. During the battle against the virus, the spleen developed fibrosis—scar‑like tissue buildup—and the organization of immune cells within it became disrupted. These structural changes interfered with the interactions needed to activate T cells, which are essential for adaptive immunity and for recognizing and destroying infected cells.

Consequently, the mice remained less capable of mounting effective immune responses to new challenges. Even though the original infection was controlled, their immune defenses continued to function poorly. Dr. Paula Cebollada Rica, the study’s first author, noted, “The infection can be controlled, but that does not necessarily mean that the host has fully recovered. Our findings show that the immune‑related consequences of an acute viral infection can persist beyond the period in which the virus is detectable, leaving the animals in an immunocompromised state.”

Vaccination Prevented Lasting Immune System Damage

Having identified these long‑term effects, the scientists examined whether vaccination could avert them. They focused on immunization that prepares the immune system to recognize and combat the pathogen before infection occurs.

The results revealed a striking contrast between vaccinated and unvaccinated animals. Mice that received a vaccine before infection did not develop spleen damage or the associated immune dysfunction seen in their unvaccinated counterparts.

Their spleens retained normal architecture, and T‑cell function remained comparable to that of mice never infected. This suggests that vaccination can safeguard the immune system from some of the detrimental consequences of fighting a viral infection. In the mouse model, immunization not only prevented disease caused by the virus but also preserved the animals’ capacity to respond to future immune challenges.

“Vaccinated animals did not experience T‑cell dysfunction or splenic alterations after recovering from an acute viral infection. This means that vaccination not only prevented the disease resulting from the acute infection but also preserved the immune system’s ability to cope with new challenges,” explained Cebollada Rica.

A Hidden Benefit of Vaccines With Public Health Implications

These findings expand the known advantages of vaccination by highlighting a form of protection that is not immediately apparent. Beyond reducing the immediate effects of infection, vaccines may also help prevent persistent changes that weaken immune defenses.

Although the results were obtained in mice and do not directly establish the same effects in humans, they raise important questions about how viral infections influence long‑term immune health and how vaccination might help preserve it. The study also arrives at a time when vaccination policies and infectious‑disease prevention efforts are increasingly shaped by political considerations. The researchers stress the importance of scientific evidence in understanding the full consequences of infections, especially when policy choices could undermine coordinated public‑health strategies.

Grasping the broader benefits of vaccination could influence not only medical care but also how public‑health officials communicate the value of vaccines to the general population.

“The benefits of vaccination highlighted by this research are important not only for healthcare, but also for how we communicate the value of vaccination to the population at large,” said Meyerhans. “It is important that people are aware of the broader protection that vaccination can provide and continue to trust in vaccines as one of the most effective tools to prevent diseases. Put simply, vaccines provide strong health benefits at a relatively low cost to society.”

Source link